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The ability of the simian immunodeficiency virus SIVsmmPBj14 (SIV-PBj14) to activate and induce proliferation of quiescent
peripheral blood lymphocytes from macaques is an in vitro correlate of its acutely lethal in vivo phenotype. SIV-PBj14 differs
from other SIV strains by encoding tyrosine at amino acid 17 (Y17) in Nef, which generates an activation motif important
for signal transduction. Although intravenous inoculation of pig-tailed macaques with SIV-PBj14 uniformly leads to death
within 2 weeks, inoculation by mucosal routes results in persistent infections that progress to AIDS. In the present study,
we determined whether viruses in long-term survivors retained not only the Nef Y17 residue but also the biologic properties
associated with rapid disease and death. Viruses reisolated at early and late times after mucosal infection of macaques
with SIV-PBj14 were tested in vivo for acute lethality and in vitro for the ability to replicate in and induce activation and
proliferation of quiescent macaque lymphocytes. In addition, the coding sequence for the first 55 amino acids in Nef was
amplified from proviral DNA or plasma virion RNA by PCR or RT-PCR, respectively, and nucleotide sequences were obtained.
The results showed that the majority of the quasispecies that persisted as disease progressed not only lost biological
properties unique to SIV-PBj14, but also lost through mutation either Y17 or Y28 in Nef, which together were part of the
activation motif. In the case of Y17, these mutations were stepwise to histidine then arginine, the amino acid encoded in
this position in other SIV strains. We conclude, therefore, that replicative properties of the acutely lethal virus provide no
selective advantage during long-term infections with SIV-PBj14 and that disruption of the activation motif in Nef is associated
with loss of the acutely lethal phenotype. q 1997 Academic Press
INTRODUCTION pathogenesis of HIV. SIV and HIV are closely related
viruses, and strains of SIV that elicit disease in macaques
The extensive genetic diversity of strains of the human similar to that induced by HIV in humans have been
immunodeficiency virus (HIV) is manifest as differences identified (Desrosiers and Letvin, 1987; Murphey-Corb et
in biologic properties, leading to questions regarding the al., 1986). Furthermore, studies have shown that success-
influence of viral genotypes and phenotypes on progres- ful transmission of primate lentiviruses is a function of
sion to disease. It has been proposed that as an infected viral genotype and phenotype as well as route of expo-
person progresses to AIDS, HIV increases in pathogenic- sure. During transmission from an infected to an unin-
ity as mutations accumulate in the quasispecies (Albert fected individual, minor variants of both HIV and SIV ap-
et al., 1990; Cheng-Mayer et al., 1988; Connor et al., 1993; pear to establish infections in recipient humans and ma-
Schuitemaker et al., 1992; Tersmette et al., 1989). This caques, respectively, especially when virus exposure is
hypothesis is supported by studies in which transitions to mucosal surfaces (Ahmad et al., 1995; Cornelissen et
in HIV phenotypes from nonsyncytium-inducing (NSI) to al., 1995; Furuta et al., 1994; Wolinsky et al., 1992; Zhang
syncytium-inducing (SI) were identified in viruses iso- et al., 1993; Zhu et al., 1993; Zhu et al., 1996; Trivedi
lated as disease progressed (Connor et al., 1993; Roos et al., 1994). Direct evidence for selective transmission
et al., 1992; Schuitemaker et al., 1992; Tersmette et al., comes from a study with two molecularly cloned chimeric
1989). That these transitions often were coincident with SIV/HIV (SHIV) strains that encode the env genes from
declines in numbers of circulating CD4/ lymphocytes HIV-1HXBc2 and HIV-189.6 . SHIVHXBc2 was shown to be infec-reinforced the idea that the SI strains, which are more tious for macaques after intravenous exposure, but it
cytopathic for T-cell lines, were also more pathogenic did not establish infection by the vaginal route; however,
(Connor et al., 1993; Richman and Bozzette, 1994; Schuite- SHIV89.6 established infections by both routes (Lu et al.,maker et al., 1992). 1996).
The simian immunodeficiency virus (SIV)-macaque Among various SIV isolates characterized to date, the
model has been used extensively to gain insight into the SIVsmmPBj14 (SIV-PBj14) strain is the most pathogenic
in that it reproducibly leads to death of pig-tailed ma-
caques (Macaca nemestrina) within 6 to 12 days after1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (205) 975-6788. intravenous inoculation (Dewhurst et al., 1990; Fultz et
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al., 1990; Fultz and Zack, 1994; Schwiebert and Fultz, ities by asking the following questions. First, do the viral
quasispecies isolated from macaques that either survive1994). The pathogenesis of this strain for pig-tailed ma-
caques, however, can be altered if infection occurs or die during the acute disease phase have the same
biologic properties as SIV-PBj14? Second, irrespective ofacross a mucosal surface. Although all macaques in-
fected by mucosal routes developed the acute disease outcome, are viruses with the same phenotypes transmit-
ted in both groups? Third, does the highly pathogenicsyndrome (diarrhea, anorexia, depression, and rash)
characteristic of intravenous SIV-PBj14 infections (Fultz lentivirus SIV-PBj14 become more or less pathogenic
during long-term persistent infections?et al., 1989; Fultz and Zack, 1994; Lewis et al., 1992),
more than 50% of the animals recovered, and long-term We report here biological and molecular analyses of
viruses recovered from macaques at early and late timespersistent infections that eventually progressed to AIDS
were established (Fultz et al., 1995; this report). These after mucosal infection with SIV-PBj14. The results show
that replicative properties required for the acutely lethalresults demonstrated unequivocally that the route of in-
fection by a primate lentivirus can influence its natural phenotype apparently confer no selective advantage to
SIV-PBj14 during long-term infections. Furthermore, losshistory, especially during the acute phase.
Use of the SIV-PBj14-macaque model provides an ad- of these properties is associated with mutations that lead
to loss of Y17 in Nef or, in at least one case, to anvantage over other SIV models because this virus strain
has unique biologic properties that not only can be evalu- apparent compensatory loss of the second tyrosine (Y28)
in the ITAM.ated in vitro but also have been shown to correlate di-
rectly with rapid death in vivo (Fultz, 1991; Fultz et al.,
1990; Novembre et al., 1993; Schwiebert and Fultz, 1994). MATERIALS AND METHODS
Furthermore, one of these properties—the ability to rep-
Animals and virus
licate efficiently in resting peripheral blood mononuclear
cells (PBMC) from normal macaques—was recently Adult female (retired breeders) and young adult male
pig-tailed macaques, seronegative for antibodies to SIV,shown to be genetically linked to a specific mutation in
the nef gene. Using site-directed mutagenesis of SIV- STLV-I, and SRV, were used in this study. All animals
were housed and maintained at the University of Ala-mac239, Du et al. (1996) replaced the arginine (R) at
amino acid residue 17 and glutamine (Q) at position 18 bama at Birmingham according to Animal Welfare Act
guidelines. Inoculation of macaques by mucosal routeswith tyrosine (Y) and glutamic acid (E), respectively,
which are identical to those encoded by SIV-PBj14 nef, was described previously (Fultz et al., 1995). Briefly,
young adult pig-tailed macaques were atraumatically in-to generate a mutant virus, termed SIVmac239/YEnef.
This virus, like SIV-PBj14, replicated in resting lympho- oculated via the rectal or vaginal mucosa with a biologi-
cal clone derived from SIV-PBj14, designated bcl3 (Fultzcytes, induced T-cell activation, and caused an acute
disease, but not death, in macaques. The presence of et al., 1989). In addition, one female and one male ma-
caque were exposed vaginally or urethrally to virus de-Y17 in SIV-PBj14’s Nef, together with amino acids 18
through 31, creates an immunoreceptor tyrosine-based rived from PBMC of a macaque (52-97) that was originally
infected by the rectal route with SIV-PBj14-bcl3 and diedactivation motif (ITAM), with the structure YXXL-X7-YXXL
(Chan et al., 1995). Since both tyrosine residues in ITAM’s 9 days after exposure to virus. Two macaques (100-103,
9216) were inoculated intravenously with 105 50% tissuehave the potential to be phosphorylated, an event that
occurs during signal transduction in lymphocytes (Paw- culture infectious doses (TCID50) of a virus stock derived
at 5 months after infection from PBMC of a macaqueson, 1995), it is possible, given SIV-PBj14’s unique prop-
erties, that Nef interacts with such a pathway. While it is (3033) that was infected vaginally with SIV-PBj14-bcl3.
Periodically during the first month after infection andclear that one role of the Nef protein is to accelerate
replication in primary lymphocytes (Baur et al., 1994; de approximately every 6 weeks thereafter, blood samples
were obtained from long-term survivors for analysis ofRonde et al., 1992; Miller et al., 1994; Spina et al., 1994;
Zazopoulos and Haseltine, 1993), with the possible ex- lymphocyte subsets and virus reisolation. Heparinized
blood was separated into PBMC and plasma by densityception of SIV-PBj14, Nef does not eliminate the require-
ment for lymphocyte activation before replication of pri- gradient centrifugation on lymphocyte separation me-
dium (LSM; Organon Teknika). Lymph node biopsiesmate lentiviruses can occur (Polacino et al., 1993).
That SIV-PBj14 evolved from a minimally pathogenic were performed on some animals at 5 to 6 months after
infection; tissues were obtained at necropsy from ani-strain, SIVsmm9, as macaque PBj progressed to AIDS
suggests that this phenomenon might occur during HIV mals that were euthanized when moribund. Single-cell
suspensions of lymph nodes were prepared by mincinginfection. It is possible, however, that survival of a virus
mandates that less pathogenic viruses be selected dur- the tissue and passing it through a 1-mm2 stainless steel
wire mesh. At the time of routine blood collections, vagi-ing persistent infections. Macaques that were infected
by mucosal routes with SIV-PBj14 and survived the acute nal washes were performed by flushing the vaginal vault
with 2 ml of RPMI-1640 containing 1% gentamicin and 1%infection provide an opportunity to address such possibil-
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penicillin/streptomycin. Cells in the vaginal wash were beled monoclonal antibodies (Becton–Dickinson) and
gating lymphocytes according to forward-scatter-versus-pelleted and washed twice in RPMI-1640 medium con-
taining 10% fetal bovine serum (10%-RPMI) before being side-scatter characteristics. Induction of lymphocyte pro-
liferation in these same cultures was measured by incor-used in various assays.
poration of [3H]thymidine (DuPont NEN Research Prod-
Reisolation of virus and generation of virus stocks ucts) into cellular DNA, as described (Schwiebert and
Fultz, 1994). Stimulation indices were determined by di-The SIV-PBj14-bcl3(52-97) stock was generated by co-
viding the cpm incorporated by lymphocytes infected withculturing PBMC obtained from macaque 52-97 at death
virus by the cpm of uninfected control lymphocytes.with PBMC, previously stimulated with Concanavalin-A
(Con-A), from a normal pig-tailed macaque. Plasma, se-
PCR amplification, cloning, and sequence analysisrum, PBMC, vaginal wash cells and fluid, or mononuclear
cells from lymph nodes were cocultured with uninfected PBMC, single-cell suspensions of lymph node biopsy
pig-tailed macaque PBMC to amplify viruses. Superna- tissue, and cells from vaginal washes were cocultured
tants were harvested when the reverse transcriptase (RT) with normal macaque PBMC. When virus replication was
activity in culture medium was approximately 5 1 105 detected, cells from these cultures were pelleted and
counts per minute or greater. Cells and debris were pel- washed twice in 10 ml of phosphate-buffered saline. Ge-
leted by centrifugation; the supernatant was filtered nomic DNA was extracted using the QIAamp Blood kit
through an 0.45-mm filter and aliquoted for storage at (Qiagen Inc.), and 580-bp fragments covering approxi-0807. The TCID50 of virus stocks was determined by lim- mately 75% of the 5* end of nef were generated by PCR
iting dilution and infection of Con-A-stimulated macaque amplification with the following primers: Nef I, 5*-GTG-
PBMC. Generation of SIVsmm9 and SIV-PBj14 stocks CTCCAGAGCCTCTCAAGGACGCT-3*, and Nef IV, 5*-
was described previously (Schwiebert and Fultz, 1994). CGGTAAATGTCTCAGATGAAGCTCA-3*. After purifica-
Cocultured cells were washed, and cell pellets were tion with the Geneclean kit (Bio 101), PCR amplification
stored at 0807 for subsequent proviral DNA extraction products were cloned into the TA cloning vector and then
and sequence analysis. transfected into competent Escherichia coli cells (TA
Cloning kit; Invitrogen). DNA from multiple clones, repre-
Assays for SIV p27gag and cytokines senting at least two independent PCR amplifications, was
sequenced by the dideoxynucleotide chain terminationThe concentration of SIV p27gag antigen in plasma was
method (Sequenase Version 2 kit; U.S. Biochemicaldetermined with an SIV-p27 enzyme-linked immunosor-
Corp.), using the primer Nef III, 5*-TCATCAGAGTTCAGA-bent assay (ELISA) antigen capture kit (Coulter), ac-
TAGCCTACCT-3*. Some samples for sequence analysiscording to the manufacturer’s instructions. Interleukin 6
were generated by RT-PCR after ultracentrifugation of(IL-6) and tumor necrosis factor alpha (TNF-a) concentra-
plasma to concentrate virions. Viral RNA was extractedtions in serum were assayed with commercial ELISA kits
from the pellet using phenol-chloroform, and cDNA was(Innotest hTNF-a, Innogenetics, Belgium, distributed by
synthesized from the RNA template using Moloney Mu-Biosource International; Cytoscreen Human IL-6 ELISA,
rine Leukemia Virus reverse transcriptase and the 1st-Biosource International).
Strand cDNA Synthesis kit (Clontech Laboratories). Con-
Infection of quiescent macaque PBMC sensus sequences were generated using the Assembly
Lign program (International Biotechnologies Inc.). TheQuiescent macaque PBMC were obtained by separa-
base designation threshold value for calculating a con-tion of blood on LSM and were cultured immediately
sensus sequence was 80%.without mitogen stimulation in 10%-RPMI. Approximately
1.5 1 107 PBMC were infected with 104 TCID50 of virus
RESULTSstocks in 2 ml of 10%-RPMI without IL-2; the virus was
allowed to adsorb for 2 to 4 hr, after which time cultures Clinical disease course following inoculation
were maintained in 10 ml of 10%-RPMI. Every 5 days, 3
ml of medium were replaced and cell-free RT activity The early disease course of six macaques infected
after mucosal exposure to SIV-PBj14-bcl3 was describedwas determined. Each set of experiments included mock-
infected and SIVsmm9- and SIV-PBj14-infected cultures, previously (Fultz et al., 1995). Since that report, three of
the macaques were euthanized after development of anas negative and positive controls, and were performed at
least twice with PBMC from different normal macaques. AIDS-like disease (Table 1). Subsequently, two additional
macaques were infected mucosally with virus reisolatedActivation of cultured PBMC populations was deter-
mined by measuring the percentage of cells that ex- 9 days after rectal infection of macaque 52-97; one ma-
caque was exposed by the vaginal route (3006) and onepressed CD25 (IL-2 receptor a chain). Analyses were
performed with a FACS-STAR flow cytometer (Becton – by the penile urethra (118F). These two animals also
developed acute disease characterized by diarrhea, de-Dickinson) using murine anti-human fluorescence-la-
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TABLE 1
Outcome of Infection of Macaques by Mucosal Routes with SIV-PBj14-bcl3
Animal Route Dose Outcome
52-97 Rectal 104 TCID50 Died Day 9
72-57 Rectal 103 TCID50 Died Day 14
72-73 Rectal 103 TCID50 Died 24 months p.i., AIDS
82-50 Rectal 104 TCID50 Died 15 months p.i., AIDS, chronic malaria
3006 Vaginala 104 TCID50 Died Day 14
3033 Vaginal 103 TCID50 Died 5 months p.i., AIDS
3097 Vaginal 104 TCID50 Alive 30 months p.i., AIDS
118F Urethrala 104 TCID50 Died 6 months p.i., AIDS
a Inoculum: Virus reisolated from macaque 52-97 at time of death after rectal inoculation of SIV-PBj14-bcl3, with which the remaining animals
were infected.
pression, and anorexia; the female macaque died on lates recovered from six macaques within the first 15
days after mucosal inoculation of SIV-PBj14-bcl3 wereDay 14 after infection, but the male macaque survived,
developed progressive disease, and was euthanized 6 used to infect quiescent PBMC from normal macaques,
and culture supernatants were monitored for productionmonths after infection. There was no correlation between
virus dose in the inoculum and disease course. All of the of virus. Regardless of an animal’s survival outcome, vi-
ruses reisolated during primary viremia not only repli-animals that survived seroconverted within 4 to 6 weeks.
Although all macaques infected by the mucosal route cated to high levels, as measured by RT activity (data
not shown), but also activated PBMC, as evidenced bydeveloped an acute disease syndrome, virus replication
and cytokine production were markedly decreased in increased percentages of cells expressing CD25 (Fig.
2A). Cells from these same cultures with high levels ofanimals that survived the primary viremia. Compared to
those animals that died within 2 weeks, mean plasma CD25/ lymphocytes proliferated and incorporated [3H]-
thymidine into cellular DNA (Fig. 2B). The extent of prolif-SIV p27gag antigenemia was one to two log10 less in ani-
mals that survived initial infection (Fig. 1A); this difference eration was directly related to virus production; stimula-
tion indices for cultures infected with SIV-PBj14-bcl3-de-was greater when the titers of infectious virus in plasma
were determined. The mean titer of infectious virus in rived viruses increased as the RT activity of viruses in the
culture supernatants increased (data not shown). Theseplasma of survivors was approximately 103 TCID50 ,
whereas that of animals that died acutely was 5 1 105 results showed that all viruses recovered early after mu-
cosal infection retained in vitro biologic propertiesTCID50 . Either none or only minimal amounts of IL-6 and
TNF-a were detected in serum from the surviving ma- unique to SIV-PBj14. Furthermore, virus recovered from
52-97 on Day 9 was used to infect macaques 3006 andcaques (Figs. 1B and 1C). In contrast, all macaques that
died during the acute disease phase after infection with 118F; both animals developed the acute disease syn-
drome, indicating that the virulent in vivo phenotype wasSIV-PBj14-bcl3 by mucosal routes had virus burdens and
cytokine levels comparable to those found in macaques also retained.
that died early after intravenous inoculation, as reported
Biologic properties of viruses isolated from long-termpreviously (Schwiebert and Fultz, 1994). Consistent with
survivors of mucosal infectionthe observation that virus dose did not correlate with
disease outcome (Table 1), plasma levels of IL-6 and Of more importance was whether viruses with the
TNF-a also showed no correlation; macaque 72-57, that above properties persisted as the dominant phenotype of
received the lower dose (103 TCID50), had the highest the quasispecies during long-term infections. Therefore,
levels of the two cytokines among all animals that died viruses isolated at 5 to 6 months after infection from
acutely (Fig. 1). lymph node cells or PBMC of those macaques that sur-
vived the acute disease syndrome were characterized.
Biologic properties of viruses isolated during the
The isolates varied in their ability to replicate in and
acute disease phase after mucosal infection
induce activation and proliferation of quiescent macaque
PBMC (Figs. 3–5). Virus isolated from macaque 72-73 atThe ability of SIV-PBj14 to replicate in and to activate
and induce proliferation of resting macaque PBMC is 6 months retained the phenotype of SIV-PBj14, while that
from animal 118F at 5 months appeared to retain somedirectly correlated with the acutely lethal disease. Thus,
it was of interest to determine whether these properties ability to replicate in and induce proliferation of resting
PBMC. In contrast, isolates recovered from macaqueswere retained by viruses circulating in animals that ulti-
mately survived the acute disease syndrome. Virus iso- 82-50 (6 months), 3033 (5 months), and 3097 (5 months
AID VY 8469 / 6a2f$$$162 03-01-97 03:02:36 vira AP: Virology
86 SCHWIEBERT, TAO, AND FULTZ
acute disease syndrome in vivo. The phenotype of the
quasispecies obtained from macaque 3033 at death 5
months after infection resembled that of SIVsmm9, indi-
cating that it should not induce the acute disease syn-
drome and death in macaques. To verify this prediction,
macaques 100-103 and 9216 were inoculated intrave-
nously with a high dose of this virus. This route was used
because 100% of pig-tailed macaques inoculated by this,
rather than by a mucosal, route died within 12 days (Fultz
et al., 1989; Fultz and Zack, 1994; Lewis et al., 1992;
Schwiebert and Fultz, 1994). Neither animal showed
signs of acute disease following inoculation, but persis-
tent infections accompanied by seroconversion were es-
tablished. In vitro assays demonstrated that the virus
reisolated from 100-103 on Day 6 after infection repli-
cated poorly in resting macaque PBMC; however, virus
from 9216 replicated as efficiently as SIV-PBj14 (not
shown). Likewise, the percentage of cells expressing
CD25 and proliferation of PBMC in cultures of virus from
100-103 were similar to those in the uninfected and
SIVsmm9-infected cultures (Fig. 5), whereas virus from
9216 had properties like SIV-PBj14 (Fig. 6). That virus
isolated from macaque 9216 on Day 6 resembled SIV-
PBj14 phenotypically suggests that viruses with these
FIG. 1. Peak plasma levels of SIV p27gag (A) and inflammatory cyto-
kines IL-6 (B) and TNF-a (C) in pig-tailed macaques infected with SIV-
PBj14-bcl3 by mucosal routes; all measurements were done on plasma
obtained between 7 and 16 days after inoculation. Symbols represent
values for individual animals and indicate route of inoculation as vagi-
nal (j), urethral (m), or rectal (l). Values obtained at time of acute
death for macaques (n  8) inoculated intravenously (l) are shown
for comparison and were published previously (Schwiebert and Fultz,
1994). Horizontal lines indicate arithmetic means.
and later) exhibited the phenotype of SIVsmm9, the par-
ent virus of SIV-PBj14.
FIG. 2. Activation (A) and proliferation (B) of resting macaque lympho-
cytes by viruses isolated within 15 days after inoculation of macaques
In vivo analysis of SIV-PBj14-bcl3 reisolated from a with SIV-PBj14-bcl3 by mucosal routes. All viruses were recovered from
long-term survivor PBMC except as indicated by Vw, vaginal wash. Animals inoculated
by the same route are grouped and indicated by bars with identical
As definitive evidence for loss of the acutely lethal fills. The cells were evaluated on the days, indicated in parentheses,
phenotype by SIV-PBj14-bcl3 during long-term infection, after infection of resting PBMC. Control, uninfected PBMC. Results from
a representative experiment are shown.we determined whether these viruses could induce the
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FIG. 5. Loss of the ability to activate and induce proliferation of
resting PBMC by SIV-PBj14-bcl3 progeny viruses from a persistently
infected and a recipient macaque. Virus isolated from macaque 3033
at time of death (5 months after vaginal inoculation) was used to infect
macaque 100-103 intravenously. All viruses were isolated from PBMC
at the indicated times after infection. Results from a representative
experiment are shown.
ease syndrome, exhibited biological properties (Figs. 1
and 2) associated with Y17 in Nef of SIV-PBj14 and SIV-
mac239YEnef (Du et al., 1996, 1995).
With the exception of proviruses from macaque 118F,
which included one variant encoding histidine at position
17 (H17), all sequenced proviruses in PBMC obtained
FIG. 3. Activation (A) and proliferation (B) of resting macaque PBMC within the first 6 weeks after mucosal infection retained
induced by viruses isolated from lymph node biopsies 6 months after Y17 in the Nef protein (Fig. 7). Between 3 and 6 months
inoculation of macaques with SIV-PBj14-bcl3 by mucosal routes. See after infection, however, amino acids encoded at position
legend to Fig. 2 for explanations.
17 in nef of viruses in various tissues from different ani-
mals included tyrosine, histidine, or arginine (R17). Al-
though the 6-month quasispecies found in the lymphproperties were present in low numbers in the inoculum
node of macaque 72-73 phenotypically resembled SIV-and were amplified early after infection of 9216.
PBj14, only 1 of 11 clones retained the Y17. The re-
maining 10 clones and all of the clones sequenced fromGenetic analysis of Nef
82-50, whose quasispecies had a phenotype similar to
Because the presence of Y17 in the Nef protein ap- that of SIVsmm9, had histidine residues at position 17.
peared to correlate with the acutely lethal phenotype After 1 year of infection of 72-73, Y17 in Nef was replaced
and unique in vitro biologic properties of SIV-PBj14 and completely by either histidine or arginine, the latter of
SIVmac239YEnef, the first 55 amino acids of the nef which is the amino acid found at this position in SIVsmm9
genes of viruses reisolated from mucosally infected ma- and other SIV strains, including SIVmac239. A combina-
caques at various times were sequenced. Again, regard- tion of these two amino acids also was present in provi-
less of the survival outcome of the animal (Table 1), vi- ruses from macaque 118F at 6 months (time of death).
ruses recovered between Days 9 and 15 after infection That the biologic phenotypes of the viral quasispecies
encoded Y17 (Fig. 7). These results correlated with the from macaques 72-73 and 82-50 were different, but H17
observation that viruses obtained during this period, in-
cluding those from animals that survived the acute dis-
FIG. 4. Loss of the ability to induce proliferation of resting PBMC by FIG. 6. Induction of proliferation of resting macaque PBMC by virus
isolated from PBMC of macaque 9216 after intravenous inoculation ofviruses isolated from macaque 3097 at the times indicated after vaginal
inoculation of SIV-PBj14-bcl3. Results from two independent experi- virus recovered from macaque 3033 at time of death. Values are means
of two experiments with PBMC from two normal macaques.ments with PBMC from different normal macaques are shown.
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FIG. 7. Sequences of the first 55 amino acids in Nef of viruses isolated from macaques infected with SIV-PBj14-bcl3 by mucosal routes. Sequences
from each animal are grouped and are relative to that of SIV-PBj14 and SIVsmm9. All of the sequences were derived from proviral DNA in cultures
of PBMC, except where indicated, at the given times after inoculation. Some proviral DNA was obtained from lymph node biopsy tissues (LN) or
from cultures infected by vaginal wash fluids (vw). For the sequences from macaques 52-97, 72-73, 82-50, and 72-57, RT-PCR was used to amplify
virion RNA from plasma collected on Days 9 to 15 after infection. Sequences derived from samples obtained at time of death are indicated by †.
The numbers to the left of the sequences reflect the number of clones with the given amino acid relative to Y17 only. The other amino acids are
consensus sequences for all clones from the given animal and time, and therefore, may not be present in the same relative proportions as amino
acids at residue 17. The dotted lines are for reference relative to Y17 and Y28, and the horizontal bar identifies the ITAM.
predominated in both, suggests that the SIV-PBj14 phe- encoded only arginine (Y17R), whereas proviruses in
PBMC contained a mixture of H17 and R17 (Fig. 7). How-notype might require other regions of the genome as
well as Nef Y17. ever, when the supernatant from 3033’s 5-month PBMC
culture (used to inoculate 100-103 and 9216) was pas-Of the two macaques that survived long-term after vag-
inal infection, the viruses recovered from the vaginal saged in vitro in normal pigtailed macaque PBMC, 3 of
10 clones had retained the Y17 (Fig. 8), indicating prefer-wash of 3033 at 5 months (when the animal died of AIDS)
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FIG. 8. Sequences of the first 55 amino acids in Nef of viruses isolated from macaques 100-103 and 9216 infected intravenously with virus
recovered from macaque 3033 at death. The data for macaque 3033 include the 21 clones from PBMC (see Fig. 7) plus sequences from 10 additional
clones generated from PCR products of in vitro passage of 3033’s recovered virus. Sequences from each animal are grouped and are relative to
that of SIV-PBj14 and SIVsmm9. See Fig. 7 legend for additional information. Arrows identify the positions of Y17 and Y28 in SIV-PBj14.
ential amplification of viruses with SIV-PBj14’s genotype. creased virus loads in the survivors may reflect more
limited replication of SIV-PBj14 in cell types, such asThis result and the finding of 2 of 18 clones with Y17 in
virus recovered from macaque 9216 at 6 days explains macrophages and Langerhan’s cells, that populate mu-
cosal tissues, rather than in lymphocytes which would bethis latter virus’ phenotype in vitro (Fig. 6). Finally, of
particular interest was the observation that, irrespective encountered and infected preferentially after parenteral
inoculation. A recent study that examined cervicovaginalof time after infection, all of the proviruses from macaque
3097 that were evaluated retained Y17. However, begin- mucosa within the first few days after vaginal inoculation
of macaques with SIVmac251 demonstrated SIV proviralning at 3 months, Y28 in some proviruses had been re-
placed by either a cysteine or histidine and in two cases DNA in cells resembling both lymphocytes and dendritic
cells (Spira et al., 1996). If replication of the virus in muco-of virus isolated from the vaginal wash at 21 months,
there was a Y28S mutation. Mutations that change either sal tissues is restricted in any way, this delay may give
the immune system time to respond and downregulateof these tyrosines disrupt the activation motif encoded
in SIV-PBj14 Nef amino acids 17 through 31, suggesting the primary burst of virus replication. These results dem-
onstrate, however, that an extremely virulent lentivirusthat mutation and loss of Y28 may be sufficient to com-
pensate for retention of Y17. can be transmitted efficiently by mucosal routes and re-
tain its virulence during the acute stage of infection (Ta-
ble 1, macaque 3006).DISCUSSION
Our results clearly show that progression to an AIDS-
While intravenous infection of pig-tailed macaques like disease did not require that biologic properties asso-
with SIV-PBj14-bcl3 uniformly results in death in 7 to 10 ciated with the acutely lethal phenotype be retained as
days, infection across a mucosal surface can lead either the major population in the quasispecies; however, it is
to rapid death or to persistent infections that ultimately possible that these viruses may have had an impact on
progress to AIDS. Compared to animals that died acutely, pathogenesis during the acute stage of disease. In fact,
animals that survived the primary disease syndrome had most of the viruses isolated after resolution of the acute
no detectable IL-6 in serum and lower virus loads and disease syndrome exhibited phenotypes more character-
TNF-a concentrations. These results extend previous istic of prototypic SIV strains. The reversion to the paren-
ones (Schwiebert and Fultz, 1994) by demonstrating that tal SIVsmm9 phenotype was not limited to the inability
the correlation between replication of SIV-PBj14-bcl3, cy- to replicate in quiescent macaque PBMC and to activate
tokine production and acute death does not extend to the and induce proliferation of lymphocytes, but also ex-
acute disease syndrome (diarrhea, anorexia, depression, tended to in vivo infections.
lymphopenia). That is, despite having low levels of in- Loss of the SIV-PBj14 phenotype was associated with
flammatory cytokines and plasma viremia, surviving ma- step-wise mutations in Nef from Y17 to H17 to R17, the
latter of which is encoded in SIVsmm9 and other SIVcaques still developed severe acute disease. The de-
AID VY 8469 / 6a2f$$$163 03-01-97 03:02:36 vira AP: Virology
90 SCHWIEBERT, TAO, AND FULTZ
dominant properties of SIV-PBj14. Whether this propor-
tion is also valid for Y28 and its mutant forms remains
to be tested, but the phenotypes of viruses with Y28
mutations that were isolated from macaque 3097 sug-
gests that this may not be the case.
The importance of the nef gene to disease progression
in HIV-1-infected individuals has not been defined pre-
cisely, but recent studies showed no correlation in the
genotypic and phenotypic characteristics of nef when
viruses from progressors and long-term nonprogressorsFIG. 9. Evolution of SIV-PBj14-bcl3 nef gene during long-term persis-
tent infections. Nucleotide changes that occurred in codons for tyrosine were compared (Huang et al., 1995a, 1995b; Michael et
residues 17 (A) and 28 (B) in Nef are underlined. SIVsmm9 encodes a al., 1995). In this regard, loss of the ITAM by mutation of
tyrosine at residue 28 with the same TAT codon. the nef allele in SIV-PBj14-bcl3-infected macaques did
not retard the development of an AIDS-like illness. How-
ever, our results imply that viral phenotypes, such as thatstrains (Fig. 9A). Both of these changes require a single
nucleotide substitution. In the case where no change in of SIV-PBj14, that interfere with establishment of persis-
tent infections are not advantageous for the virus. In addi-Y17 was observed during 1 year of infection (Fig. 7, 3097),
it is interesting that mutations disrupted the second YXXL tion, because Nef-specific antibodies and cytotoxic T
lymphocyte responses are often elicited early after SIVmotif of the ITAM, resulting in replacement of Y28 with
cysteine, histidine, or serine (Fig. 9B). Because the TAT infections (Bourgault et al., 1992; Kirchhoff et al., 1991;
von Herrath et al., 1995; Yasutomi et al., 1993), their po-codon for Y28 is essentially invariant in other HIV-2 and
SIV strains, it appears that the Y28C, Y28H, and Y28S tential impact on different Nef alleles should be consid-
ered.mutations compensate for retention of Y17. This possibil-
ity is supported by the loss of the SIV-PBj14 phenotype While it is clear that Nef is required for efficient replica-
tion and disease induction during SIV-PBj14 infection ofin viruses isolated from macaque 3097 at late times and
suggests that the entire ITAM, and not the first YXXL macaques (Novembre et al., 1996), as well as that of
other SIV strains (Kestler et al., 1991; Whatmore et al.,SH2-binding domain alone, is required for manifestation
of the SIV-PBj14 phenotype. Furthermore, Du et al. (1996) 1995), additional regions of the genome appear to con-
tribute to the acutely lethal effects of the virus (Novembrerecently demonstrated that replacement of Y28 with phe-
nylalanine (Y28F) in the SIVmac239/YEnef strain resulted et al., 1993, 1994). Using chimeric viruses in which differ-
ent regions of the genomes of SIV-PBj14 and SIVsmm9in loss of the ability to replicate in resting PBMC. It is
possible that a very small percentage of virions in the were exchanged, Novembre et al. (1993) showed that the
envelope of SIV-PBj14 was necessary but not sufficientSIV-PBj14-bcl3 inoculum already encoded H17 and R17
and were amplified in vivo. However, this is unlikely be- for expression of this atypical phenotype. For this reason,
and multiple demonstrations that env encodes determi-cause the rates of change for Y17 and Y28 were the
same, suggesting similar selection pressures at both nants for specific biologic properties (Groenink et al.,
1993; Zhang et al., 1993), the possibility that additionalsites.
The other exception to the association between loss mutations occurred in env, other regions of the genome
or elsewhere in nef in viruses that lost the SIV-PBj14of Y17 and the SIV-PBj14 phenotype was the viral quasi-
species isolated from the lymph node of macaque 72-73 phenotype must be explored.
at 6 months after infection. Although 10 of 11 clones had
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